Recent Insider Transactions - Spyre Therapeutics (NASDAQ: SYRE)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ SYRE Spyre Therapeutics

Fairmount Funds Management LLC / director

05/14/2024

Buy

$39.29

11,323

$445K

11,323

NASDAQ SYRE Spyre Therapeutics

Milligan Sandra / director

05/14/2024

Buy

$39.29

21,980

$864K

21,980

NASDAQ SYRE Spyre Therapeutics

Albers Jeffrey W. / director

05/14/2024

Buy

$39.29

11,323

$445K

11,323

NASDAQ SYRE Spyre Therapeutics

Stelzer Laurie / director

05/14/2024

Buy

$39.29

11,323

$445K

11,323

NASDAQ SYRE Spyre Therapeutics

HENDERSON MICHAEL THOMAS / director

05/14/2024

Buy

$39.29

11,323

$445K

11,323

NASDAQ SYRE Spyre Therapeutics

Turtle Cameron / director, officer: Chief Executive Officer

02/15/2024

Buy

$9.82

400

$4K

746,907

NASDAQ SYRE Spyre Therapeutics

McKenna Mark C. / director

02/01/2024

Buy

$25.86

40,000

$1.034M

40,000

NASDAQ SYRE Spyre Therapeutics

McKenna Mark C. / director

02/01/2024

Sell

$10.39

477,000

$4.956M

NASDAQ SYRE Spyre Therapeutics

Turtle Cameron / director, officer: Chief Executive Officer

02/01/2024

Buy

$25.86

277,750

$7.183M

277,750

NASDAQ SYRE Spyre Therapeutics

Burrows Scott L / officer: Chief Financial Officer

02/01/2024

Buy

$25.86

70,000

$1.810M

70,000

NASDAQ SYRE Spyre Therapeutics

King-Jones Heidy / officer: See Remarks

02/01/2024

Buy

$25.86

63,000

$1.629M

63,000